Skip to main navigation Skip to search Skip to main content

Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devices

  • Arwa Younis
  • , Tania Arous
  • , Robert Klempfner
  • , Adnan Kharsa
  • , Scott McNitt
  • , Susan Schleede
  • , Bronislava Polonski
  • , Zeinab Abdallah
  • , Ruppinder Buttar
  • , Christopher Bodurian
  • , Chadi Tabaja
  • , Hagai D. Yavin
  • , Farooq Shamroz
  • , Oussama M. Wazni
  • , Steven D. Wittlin
  • , Mehmet Aktas
  • , Ilan Goldenberg

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1595-1604
Number of pages10
JournalJournal of Cardiovascular Electrophysiology
Volume34
Issue number8
DOIs
StatePublished - Aug 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Keywords

  • SGLT2i
  • atrial fibrillation
  • atrial tachyarrhythmias
  • canagliflozin
  • cardiac implantable electronic device
  • dapagliflozin
  • defibrillator
  • empagliflozin
  • sodium glucose cotransporter 2 inhibitors
  • ventricular tachycardia

Cite this